ICOSAVAX INC (ICVX) Forecast, Price Target & Analyst Ratings
NASDAQ:ICVX • US45114M1099
15.31 USD
-0.14 (-0.91%)
At close: Feb 16, 2024
15.39 USD
+0.08 (+0.52%)
After Hours: 2/16/2024, 8:05:55 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ICOSAVAX INC (ICVX).
Forecast Snapshot
Consensus Price Target
$18.87
+ 23.25% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2023
EPS Estimate-$0.53
Revenue Estimate
ChartMill Buy Consensus
78.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$18.87
Upside
+ 23.25%
From current price of $15.31 to mean target of $18.87, Based on 12 analyst forecasts
Low
$15.15
Median
$15.81
High
$26.25
Price Target Revisions
1 Month
0.00%
3 Months
-20.71%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for ICVX. The average price target is 18.87 USD. This implies a price increase of 23.25% is expected in the next year compared to the current price of 15.31.
The average price target has been revised downward by 20.71% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.33%
ICVX was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ICVX.
In the previous month the buy percentage consensus was at a similar level.
ICVX was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-02 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-11-17 | Guggenheim | Initiate | Buy |
| 2023-10-02 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-04-25 | Oppenheimer | Reiterate | Outperform |
| 2023-01-04 | Oppenheimer | Initiate | Outperform |
| 2021-08-23 | William Blair | Initiate | Outperform |
| 2021-08-23 | Cowen & Co. | Initiate | Outperform |
| 2021-08-23 | Evercore ISI Group | Initiate | Outperform |
| 2021-08-23 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2023
EPS Estimate-$0.53
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q9.41%
Number of Analysts7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
-100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
9.77%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 100% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.62M | 7.8M 381.48% | 580K -92.56% | -100.00% | 1.02M | 50.196M 4,821.18% | 203.19M 304.79% | 296.99M 46.16% | 526.9M 77.41% | 747.83M 41.93% | ||
| EBITDA YoY % growth | -18.71M -246.48% | -65.79M -251.63% | -94.2M -43.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.71M -246.48% | -65.87M -252.06% | -95.06M -44.31% | -110.752M -16.51% | -123.808M -11.79% | -149.879M -21.06% | -128.933M 13.97% | -37.013M 71.29% | 6.596M 117.82% | 271.37M 4,014.16% | 409.68M 50.97% | |
| Operating Margin | -1,154.94% | -844.49% | -16,389.66% | N/A | N/A | -14,694.00% | -256.86% | -18.22% | 2.22% | 51.50% | 54.78% | |
| EPS YoY % growth | N/A | N/A | -2.31 31.94% | -2.18 5.52% | -2.15 1.56% | -2.42 -12.52% | -1.81 25.11% | 0.88 148.73% | 2.13 141.62% | 4.77 123.92% | 4.79 0.43% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.53 9.41% | -0.55 8.29% | -0.54 8.63% | -0.54 -22.28% | -0.54 -0.57% | -0.59 -7.51% | -0.59 -9.74% | -0.60 -11.85% | -0.60 -11.95% | -0.61 -3.45% | -0.60 -1.72% | -0.61 -1.69% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.285M -12.55% | -30.09M -13.46% | -30.6M -5.66% | -30.6M -21.04% | -31.11M -9.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.53%
EPS Next 5 Year
18.96%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.57%
Revenue Next 5 Year
194.45%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ICOSAVAX INC / ICVX Forecast FAQ
What is the average price target for ICOSAVAX INC (ICVX) stock?
12 analysts have analysed ICVX and the average price target is 18.87 USD. This implies a price increase of 23.25% is expected in the next year compared to the current price of 15.31.
What are the consensus estimates for ICVX stock next earnings?
The consensus EPS estimate for the next earnings of ICOSAVAX INC (ICVX) is -0.53 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for ICVX stock?
The consensus rating for ICOSAVAX INC (ICVX) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.